 Mia Smith
Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 17 | 2025 | 878 | 4.750 |
Why?
| | Diabetes Mellitus, Type 1 | 10 | 2025 | 3952 | 1.730 |
Why?
| | Autoantibodies | 8 | 2025 | 1513 | 1.510 |
Why?
| | Clonal Anergy | 6 | 2018 | 53 | 1.360 |
Why?
| | Islets of Langerhans | 5 | 2025 | 853 | 1.230 |
Why?
| | Autoimmunity | 6 | 2025 | 935 | 1.000 |
Why?
| | Insulin-Secreting Cells | 3 | 2025 | 393 | 0.990 |
Why?
| | Lymphocyte Activation | 4 | 2025 | 1140 | 0.790 |
Why?
| | Prediabetic State | 2 | 2018 | 251 | 0.760 |
Why?
| | T-Lymphocytes | 6 | 2025 | 2017 | 0.740 |
Why?
| | Autoimmune Diseases | 2 | 2023 | 471 | 0.650 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2017 | 16 | 0.530 |
Why?
| | Graves Disease | 1 | 2017 | 32 | 0.520 |
Why?
| | Antibody-Producing Cells | 1 | 2017 | 30 | 0.510 |
Why?
| | Thyroid Gland | 1 | 2017 | 93 | 0.500 |
Why?
| | Magnetic Fields | 1 | 2017 | 24 | 0.500 |
Why?
| | Cell Separation | 1 | 2017 | 306 | 0.460 |
Why?
| | Diabetic Nephropathies | 1 | 2017 | 322 | 0.400 |
Why?
| | Receptors, Antigen, B-Cell | 3 | 2025 | 131 | 0.330 |
Why?
| | Nanoparticles | 1 | 2017 | 524 | 0.320 |
Why?
| | Insulin | 4 | 2023 | 2526 | 0.230 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 849 | 0.210 |
Why?
| | Humans | 16 | 2025 | 147293 | 0.210 |
Why?
| | Flow Cytometry | 2 | 2018 | 1172 | 0.200 |
Why?
| | CD79 Antigens | 2 | 2014 | 16 | 0.190 |
Why?
| | Immune Tolerance | 2 | 2017 | 386 | 0.190 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 15 | 0.180 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 367 | 0.170 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 443 | 0.160 |
Why?
| | Mice, Inbred NOD | 2 | 2018 | 616 | 0.140 |
Why?
| | Age of Onset | 1 | 2020 | 568 | 0.140 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2018 | 13 | 0.130 |
Why?
| | B7-2 Antigen | 1 | 2017 | 27 | 0.130 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 39 | 0.130 |
Why?
| | Animals | 8 | 2025 | 38410 | 0.130 |
Why?
| | Ikaros Transcription Factor | 1 | 2018 | 23 | 0.130 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1224 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2890 | 0.130 |
Why?
| | HLA-DQ Antigens | 1 | 2018 | 174 | 0.130 |
Why?
| | HLA-DR Antigens | 1 | 2018 | 220 | 0.120 |
Why?
| | Cell Count | 1 | 2017 | 321 | 0.120 |
Why?
| | Epitopes | 1 | 2017 | 475 | 0.110 |
Why?
| | Monocytes | 1 | 2018 | 539 | 0.110 |
Why?
| | Pandemics | 1 | 2023 | 1720 | 0.110 |
Why?
| | Immunoglobulins | 1 | 2014 | 163 | 0.100 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 6041 | 0.100 |
Why?
| | Antibodies, Viral | 2 | 2022 | 687 | 0.100 |
Why?
| | Cloning, Molecular | 1 | 2014 | 539 | 0.100 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 95 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2017 | 4169 | 0.090 |
Why?
| | Gammaherpesvirinae | 1 | 2012 | 45 | 0.090 |
Why?
| | B-Lymphocyte Subsets | 1 | 2012 | 76 | 0.090 |
Why?
| | Autoantigens | 1 | 2014 | 429 | 0.090 |
Why?
| | Antigens, CD | 1 | 2014 | 562 | 0.080 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2011 | 59 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 6011 | 0.080 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 148 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 444 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2016 | 932 | 0.080 |
Why?
| | Mice | 6 | 2018 | 18491 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2016 | 1162 | 0.080 |
Why?
| | Female | 5 | 2025 | 80076 | 0.080 |
Why?
| | Male | 4 | 2025 | 73950 | 0.070 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 345 | 0.070 |
Why?
| | Time Factors | 1 | 2020 | 7173 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2458 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3216 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2625 | 0.060 |
Why?
| | Adolescent | 1 | 2025 | 22825 | 0.060 |
Why?
| | Inflammation | 3 | 2022 | 2920 | 0.050 |
Why?
| | Child | 1 | 2025 | 22979 | 0.050 |
Why?
| | Lymphocyte Depletion | 2 | 2014 | 133 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 36 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 29 | 0.050 |
Why?
| | Adult | 1 | 2025 | 41405 | 0.040 |
Why?
| | Interferons | 1 | 2022 | 186 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 784 | 0.030 |
Why?
| | Signal Transduction | 1 | 2011 | 5272 | 0.030 |
Why?
| | Mice, Transgenic | 2 | 2012 | 2197 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2016 | 86 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 263 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 335 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2014 | 3153 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 334 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2014 | 34 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 182 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 590 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2014 | 165 | 0.020 |
Why?
| | Cell Movement | 1 | 2018 | 966 | 0.020 |
Why?
| | Rituximab | 1 | 2014 | 211 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 85 | 0.020 |
Why?
| | Inositol Polyphosphate 5-Phosphatases | 1 | 2011 | 4 | 0.020 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2011 | 15 | 0.020 |
Why?
| | Gene Targeting | 1 | 2011 | 81 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2011 | 219 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 325 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2011 | 93 | 0.020 |
Why?
| | Tyrosine | 1 | 2011 | 218 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2011 | 337 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 1049 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3660 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1481 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 451 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1721 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2014 | 1514 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1488 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3565 | 0.010 |
Why?
|
|
Smith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|